Cargando…

Programmed cell death in alcohol-associated liver disease

Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Tatsunori, Nagy, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641549/
https://www.ncbi.nlm.nih.gov/pubmed/32951412
http://dx.doi.org/10.3350/cmh.2020.0142
_version_ 1783605939031506944
author Miyata, Tatsunori
Nagy, Laura E.
author_facet Miyata, Tatsunori
Nagy, Laura E.
author_sort Miyata, Tatsunori
collection PubMed
description Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a crucial role in progression of ALD involving crosstalk between hepatocytes and immune cells. Multiple pathways of PCD, including apoptosis, necroptosis, autophagy, pyroptosis and ferroptosis, are reported in ALD. Interestingly, PCD pathways are intimately linked and interdependent, making it difficult to therapeutically target a single pathway. This review clarifies the multiple types of PCD occurring in liver and focuses on crosstalk between hepatocytes and innate immune cells in ALD.
format Online
Article
Text
id pubmed-7641549
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-76415492020-11-13 Programmed cell death in alcohol-associated liver disease Miyata, Tatsunori Nagy, Laura E. Clin Mol Hepatol Review Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a crucial role in progression of ALD involving crosstalk between hepatocytes and immune cells. Multiple pathways of PCD, including apoptosis, necroptosis, autophagy, pyroptosis and ferroptosis, are reported in ALD. Interestingly, PCD pathways are intimately linked and interdependent, making it difficult to therapeutically target a single pathway. This review clarifies the multiple types of PCD occurring in liver and focuses on crosstalk between hepatocytes and innate immune cells in ALD. The Korean Association for the Study of the Liver 2020-10 2020-09-21 /pmc/articles/PMC7641549/ /pubmed/32951412 http://dx.doi.org/10.3350/cmh.2020.0142 Text en Copyright © 2020 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Miyata, Tatsunori
Nagy, Laura E.
Programmed cell death in alcohol-associated liver disease
title Programmed cell death in alcohol-associated liver disease
title_full Programmed cell death in alcohol-associated liver disease
title_fullStr Programmed cell death in alcohol-associated liver disease
title_full_unstemmed Programmed cell death in alcohol-associated liver disease
title_short Programmed cell death in alcohol-associated liver disease
title_sort programmed cell death in alcohol-associated liver disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641549/
https://www.ncbi.nlm.nih.gov/pubmed/32951412
http://dx.doi.org/10.3350/cmh.2020.0142
work_keys_str_mv AT miyatatatsunori programmedcelldeathinalcoholassociatedliverdisease
AT nagylaurae programmedcelldeathinalcoholassociatedliverdisease